Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasible Study on a New Technique of ZIPPER Aortic Arch Stentgraft System in the Treatment of Aortic Arch Disease

NCT05872282 is registered in ClinicalTrials.gov with Hangzhou Endonom Medtech Co., Ltd. as lead sponsor.

NCT NCT05872282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05872282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasible Study on a New Technique of ZIPPER Aortic Arch Stentgraft System in the Treatment of Aortic Arch Disease
Lead sponsor
Hangzhou Endonom Medtech Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
April 28, 2023
Completion date
April 28, 2025
Enrollment
24 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

aortic diseases